New model IDs inflammatory asthma without sputum

January 4, 2017

(HealthDay)—A new prediction model identifies eosinophilic asthma without the need for sputum induction, according to a study published online Dec. 28 in Allergy.

Bart Hilvering, M.D., from University Medical Centre Utrecht in the Netherlands, and colleagues compared the activation state of eosinophils and neutrophils in peripheral blood to sputum analysis to assess asthma phenotype and monitor disease. The training cohort included 115 adult asthma , while the validation cohort included 34 patients.

The researchers found that a combination of data from multiple sources (blood eosinophil count, fractional exhaled nitric oxide, an asthma control questionnaire, medication use, nasal polyposis, aspirin sensitivity, and neutrophil/eosinophil responsiveness upon stimulation with formyl-methionyl-leucyl phenylalanine) identified sputum eosinophilia with 90.5 percent sensitivity and 91.5 percent specificity in the training cohort. Sensitivity and specificity were 77 and 71 percent, respectively, in the validation cohort, which had a relatively high percentage of patients on .

"The proposed identifies eosinophilic asthma without the need for sputum induction," the authors write. "The model forms a non-invasive and externally validated test to assess eosinophilic in patients not on oral corticosteroids."

Explore further: Nasal, pharyngeal EPX levels linked to sputum eosinophilia

More information: Full Text (subscription or payment may be required)

Related Stories

Nasal, pharyngeal EPX levels linked to sputum eosinophilia

December 16, 2015
(HealthDay)—For individual patients with poorly-controlled asthma, nasal and pharyngeal eosinophil peroxidase (EPX) levels are strongly associated with the eosinophil percentage of induced sputum, according to a study published ...

A large subgroup of mild-to-moderate asthma is persistently non-eosinophilic

January 6, 2012
A large percentage of patients with mild-to-moderate asthma have persistently non-eosinophilic disease which may not respond to currently available anti-inflammatory treatments, according to a new study.

Sex hormones, inflammation affect asthma in obese women

March 29, 2016
(HealthDay)—Sex hormones and systemic inflammation may be mediating the obese-asthma phenotype, according to a study published online March 23 in Allergy.

CPAP improves asthma control, QoL for adults with asthma, OSA

October 20, 2016
(HealthDay)—For adults with asthma and obstructive sleep apnea syndrome (OSAS), continuous positive airway pressure (CPAP) is associated with improved asthma control, quality of life, and lung function, according to a study ...

Urine metabolomics linked to clinical parameters of asthma

May 23, 2016
(HealthDay)—Increased urine metabolomic lipid metabolites are associated with clinical parameters in non-obese asthma patients, according to a study published online May 18 in Allergy.

Obese asthma patients have reduced treatment response

June 25, 2012
(HealthDay) -- Compared with lean patients, obese patients with asthma have higher neutrophil counts and a reduced response to corticosteroid treatment, according to a study published online June 12 in Allergy.

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.